Skip to content

H.R. 2570 · 118th Congress (2023–2025)

Safeguarding Women’s and Children’s Health Act of 2023

This bill imposes reporting requirements relating to abortion drugs.

The Food and Drug Administration (FDA) must require health care practitioners to report (1) any death or adverse event associated with the use of an abortion drug, whether or not the adverse event is considered drug-related; and (2) each time the practitioner prescribes, dispenses, or administers such a drug.

The FDA must establish online portals for health care practitioners to report such information and for patients to self-report adverse events.

The Centers for Disease Control and Prevention must aggregate the collected information and annually publish data about such drugs, including the number of prescriptions and adverse events occurring within 120 days of use.

Show official title

To require more accurate reporting of abortion drug prescribing and related adverse events, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 2570’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. August Pfluger (R-TX-11)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Rep. Richard Hudson (R-NC-9)· Original · Apr 10, 2023
  2. Rep. Tim Burchett (R-TN-2)· Later · Apr 18, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Apr 10, 2023 – Apr 21, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Apr 10, 2023
  2. HouseHealthReferred Apr 21, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Safeguarding Women’s and Children’s Health Act of 2023

    Display title, Short title · Introduced in House

  2. To require more accurate reporting of abortion drug prescribing and related adverse events, and for other purposes.

    Official title · Introduced in House